Jan 16, 2025 · Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats melanoma, non-small cell lung cancer, kidney, liver, and bladder cancer, and Hodgkin lymphoma. ... Dosage form: injection for intravenous infusion Drug class: Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) Medically reviewed by Carmen Pope, BPharm ...

Nivolumab injection is also used alone or together with other medicines (eg, ipilimumab) to treat microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer (cancer of the colon or rectum) that has spread. It is given to patients who have received other cancer treatments (eg, fluoropyrimidine, oxaliplatin ...

Nivolumab injection is used alone or in combination with ipilimumab (Yervoy) to treat certain types of melanoma (a type of skin cancer) in adults and children 12 years of age or older that has spread to other parts of the body or cannot be removed by surgery. It is also used alone to prevent melanoma from returning after surgery.

OPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer. Read the indications, side effects, and more. Please see Indication and Important Safety Information.

OPDIVO (nivolumab) injection, for intravenous use Initial U.S. Approval: 2014 -----INDICATIONS AND USAGE-----OPDIVO is a human programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 ...

Feb 28, 2024 · Nivolumab is a monoclonal antibody for managing metastatic melanoma and other malignancies. The drug targets the PD1 receptor, an immune checkpoint, thus embodying a potent form of immunotherapy. This action obstructs the signal that impedes the activation of T-cells against cancerous cells. This activity discusses the drug's indications, mechanism of action, dosing and administration, and ...

Nivolumab injection. Advertisement. Advertisement. Nivolumab injection. Advertisement. ... Policy. What is this medication? NIVOLUMAB (nye VOL ue mab) is a monoclonal antibody. It treats certain types of cancer. Some of the cancers treated are colon cancer, head and neck cancer, Hodgkin lymphoma, lung cancer, and melanoma.

Nivolumab works by binding to the protein PD-L1 on the surface of some cancer cells, which keeps cancer cells from suppressing the immune system. This allows the immune system to attack the cancer cells. Nivolumab is a type of immunotherapy drug called an …

Description for Opdivo. Nivolumab is a programmed death receptor-1 (PD-1) blocking antibody. Nivolumab is an IgG4 kappa immunoglobulin that has a calculated molecular mass of 146 kDa. It is expressed in a recombinant Chinese Hamster Ovary (CHO) cell line.. OPDIVO is a sterile, preservative-free, non-pyrogenic, clear to opalescent, colorless to pale-yellow liquid that may contain light (few ...

Jun 17, 2024 · When nivolumab is administered in combination with ipilimumab, if nivolumab is withheld, ipilimumab should also be withheld. ... Opdivo (nivolumab) 240 mg/24 mL injection for intravenous use View larger images. Drugs.com Mobile App. Access drug & treatment information, identify pills, check interactions and set up personal medication records. ...